Bid HK - Search Results

1

BET bromodomain inhibitor (JQ1) and tumor angiogenesis.

Bid HK, Kerk S. Bid HK, et al. Oncoscience. 2016 Nov 23;3(11-12):316-317. doi: 10.18632/oncoscience.326. eCollection 2016. Oncoscience. 2016. PMID: 28105454 Free PMC article. No abstract available.

2

The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma.

Bid HK, Phelps DA, Xaio L, Guttridge DC, Lin J, London C, Baker LH, Mo X, Houghton PJ. Bid HK, et al. Mol Cancer Ther. 2016 May;15(5):1018-28. doi: 10.1158/1535-7163.MCT-15-0567. Epub 2016 Feb 23. Mol Cancer Ther. 2016. PMID: 26908627 Free PMC article.

3

Targeting constitutively-activated STAT3 in hypoxic ovarian cancer, using a novel STAT3 inhibitor.

McCann GA, Naidu S, Rath KS, Bid HK, Tierney BJ, Suarez A, Varadharaj S, Zhang J, Hideg K, Houghton P, Kuppusamy P, Cohn DE, Selvendiran K. McCann GA, et al. Among authors: bid hk. Oncoscience. 2014 Mar 31;1(3):216-28. doi: 10.18632/oncoscience.26. eCollection 2014. Oncoscience. 2014. PMID: 25594014 Free PMC article.

4

RAC1: an emerging therapeutic option for targeting cancer angiogenesis and metastasis.

Bid HK, Roberts RD, Manchanda PK, Houghton PJ. Bid HK, et al. Mol Cancer Ther. 2013 Oct;12(10):1925-34. doi: 10.1158/1535-7163.MCT-13-0164. Epub 2013 Sep 26. Mol Cancer Ther. 2013. PMID: 24072884 Free PMC article. Review.

5

Development, characterization, and reversal of acquired resistance to the MEK1 inhibitor selumetinib (AZD6244) in an in vivo model of childhood astrocytoma.

Bid HK, Kibler A, Phelps DA, Manap S, Xiao L, Lin J, Capper D, Oswald D, Geier B, DeWire M, Smith PD, Kurmasheva RT, Mo X, Fernandez S, Houghton PJ. Bid HK, et al. Clin Cancer Res. 2013 Dec 15;19(24):6716-29. doi: 10.1158/1078-0432.CCR-13-0842. Epub 2013 Oct 16. Clin Cancer Res. 2013. PMID: 24132923 Free PMC article.

6

ΔNp63 promotes pediatric neuroblastoma and osteosarcoma by regulating tumor angiogenesis.

Bid HK, Roberts RD, Cam M, Audino A, Kurmasheva RT, Lin J, Houghton PJ, Cam H. Bid HK, et al. Cancer Res. 2014 Jan 1;74(1):320-9. doi: 10.1158/0008-5472.CAN-13-0894. Epub 2013 Oct 23. Cancer Res. 2014. PMID: 24154873 Free PMC article.

7

Potent inhibition of angiogenesis by the IGF-1 receptor-targeting antibody SCH717454 is reversed by IGF-2.

Bid HK, Zhan J, Phelps DA, Kurmasheva RT, Houghton PJ. Bid HK, et al. Mol Cancer Ther. 2012 Mar;11(3):649-59. doi: 10.1158/1535-7163.MCT-11-0575. Epub 2011 Dec 21. Mol Cancer Ther. 2012. PMID: 22188815 Free PMC article.

8

Anti-angiogenic activity of a small molecule STAT3 inhibitor LLL12.

Bid HK, Oswald D, Li C, London CA, Lin J, Houghton PJ. Bid HK, et al. PLoS One. 2012;7(4):e35513. doi: 10.1371/journal.pone.0035513. Epub 2012 Apr 17. PLoS One. 2012. PMID: 22530037 Free PMC article.

9

Dual targeting of the type 1 insulin-like growth factor receptor and its ligands as an effective antiangiogenic strategy.

Bid HK, London CA, Gao J, Zhong H, Hollingsworth RE, Fernandez S, Mo X, Houghton PJ. Bid HK, et al. Clin Cancer Res. 2013 Jun 1;19(11):2984-94. doi: 10.1158/1078-0432.CCR-12-2008. Epub 2013 Apr 2. Clin Cancer Res. 2013. PMID: 23549869 Free PMC article.

10

Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin.

Hutzen B, Bid HK, Houghton PJ, Pierson CR, Powell K, Bratasz A, Raffel C, Studebaker AW. Hutzen B, et al. Among authors: bid hk. BMC Cancer. 2014 Mar 19;14:206. doi: 10.1186/1471-2407-14-206. BMC Cancer. 2014. PMID: 24646176 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters